Table II.
Descriptive statistics of patient characteristics in the two groups
| Characteristics | Levels | CABG (n=27) | Control (n=16) | P |
|---|---|---|---|---|
| Age (yr) | - | 61.30±9.18 | 52.19±9.93 | <0.01† |
| Gender, n (%) | Male | 20 (74.1) | 10 (62.5) | 0.649* |
| Female | 7 (25.9) | 6 (37.5) | ||
| BMI (kg/m2), mean±SD | - | 24.58±4.06 | 23.02±2.71 | 0.14† |
| Smoker, n (%) | Yes | 11 (40.7) | 5 (31.3) | 0.41* |
| No | 16 (59.26) | 11 (68.8) | ||
| HTN, n (%) | Yes | 27 (100.0) | 6 (37.5) | <0.001* |
| No | 0 | 10 (62.5) | ||
| Diabetes, n (%) | Yes | 14 (51.9) | 6 (37.5) | 0.55* |
| No | 13 (48.2) | 10 (62.5) | ||
| Dyslipidaemia, n (%) | Yes | 26 (96.3) | 7 (43.8) | <0.001* |
| No | 1 (3.7) | 9 (56.3) | ||
| MAP (mm Hg), mean±SD | - | 102.03±9.12 | 86.71±10.76 | <0.001† |
| Platelet count (×105/µl), mean±SD | - | 2.66±0.63 | 2.45±0.80 | 0.36† |
| Homocysteine (μmol/l) | - | 21.96±11.83 | 22.09±8.31 | 0.96† |
| hsCRP (nmol/l) | - | 50.48±45.90 | 53.05±33.90 | 0.83† |
| Vitamin D (nmol/l) | - | 43.32±28.62 | 59.80±40.27 | 0.16† |
| CKMB (μg/l) | - | 21.25±14.41 | 17.64±6.72 | 0.27† |
| FBS (mmol/l) | - | 6.18±1.59 | 5.54±1.25 | 0.15† |
| Serum insulin (mIU/l), mean±SD‡ | - | 29.36±20.92 | 20.34±14.95 | 0.26† |
| Homostatic model assessment of insulin resistance (HOMA-IR), mean±SD | - | 6.77±5.63 | 4.42±3.23 | 0.24† |
| Glycosylated haemoglobin, HbA1c (%), mean±SD‡ | - | 7.31±1.76 | 6.97±2.56 | 0.64† |
| TNF-α (pg/ml) | - | 17.42±34.12 | 19.14±20.72 | 0.84† |
| Leptin (μg/l) | - | 3.88±4.66 | 1.43±1.16 | <0.05† |
| Non-alcoholic steatohepatitis, n (%) | Yes | 13 (48.2) | 3 (18.8) | 0.10* |
| No | 14 (51.9) | 13 (81.3) |
*Using Chi-square test; †using independent t test; ‡only of diabetic patients (n=14) in cases and (n=6) in controls BMI, body mass index; SD, standard deviation; hsCRP, high-sensitivity C-reactive protein; MAP, mean arterial pressure; HTN, hypertension; CKMB, creatinine kinase muscle/brain; FBS, fasting blood sugar; CABG, coronary artery bypass graft